[1]
M. Lombardi, A. Batazzi, B. Martini, A. Mehmetaj, and S. Michelassi, “SGLT2 inhibitors in polycystic kidney disease (PKD): current evidence and future perspectives”, G Clin Nefrol Dial, vol. 37, no. 1, pp. 67–70, Dec. 2025.